BRUSSELS SAYS COOPERATION GROWS BETWEEN EUROPEAN ORIGINAL AND GENERIC DRUG COMPANIES
January 1st, 2014
THE EUROPEAN Commission has released a report claiming that original product and generic pharmaceutical manufacturers are increasingly cooperating, and where they strike agreements, they are less likely to restrict generic sales.Its 2013 survey on the issue said 183 patent settlement agreements were concluded between originator and generic companies in 2012 within the European Union (EU), compared to 120 in 2011. And while this is partly explained by a new generic drugs regulation in Portugal, this was “the fifth year in a row where the total number of ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.